Your shopping cart is currently empty

CIM-834 is an orally active, selective inhibitor that targets the coronavirus membrane protein (M protein), exhibiting potent inhibition of viral assembly in both SARS-CoV-2 and SARS-CoV. It binds non-covalently to the short form of the M protein (Mshort), stabilizing it and preventing its conformational change to the long form (Mlong) necessary for virion assembly, thus blocking virus particle formation. CIM-834 holds potential for research in COVID-19 and other coronavirus infections.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | CIM-834 is an orally active, selective inhibitor that targets the coronavirus membrane protein (M protein), exhibiting potent inhibition of viral assembly in both SARS-CoV-2 and SARS-CoV. It binds non-covalently to the short form of the M protein (Mshort), stabilizing it and preventing its conformational change to the long form (Mlong) necessary for virion assembly, thus blocking virus particle formation. CIM-834 holds potential for research in COVID-19 and other coronavirus infections. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.